Claire Cramm

Analyst

Tom Croy

Investment Director

Oliver Johnston-Watt

Investment Analyst

Aidan MacMillan

Investment Director

Alastair Moore

Senior Investment Manager

Andrew Noble

Partner and Member of Investment Committee

Elizabeth Young Ph.D

Investment Manager

Past deals in Ireland

BrainWaveBank

Seed Round in 2020
BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.

BrainWaveBank

Venture Round in 2020
BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.

BrainWaveBank

Seed Round in 2019
BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.

PathXL

Venture Round in 2015
PathXL is a Northern Ireland-based company specializing in digital pathology image analysis, workflow software, and educational tools. The company develops software solutions aimed at enhancing image analysis and workflow management for the pathology field. Its technology is particularly beneficial for research and educational applications within the pathology and biopharma markets. By improving the quality of diagnoses and facilitating the review and sharing of extensive clinical data, PathXL's offerings support pathologists in their critical role in diagnosing and treating various diseases, including cancer. Through its innovative tools, the company contributes to better patient outcomes and the advancement of new therapies.

PathXL

Venture Round in 2015
PathXL is a Northern Ireland-based company specializing in digital pathology image analysis, workflow software, and educational tools. The company develops software solutions aimed at enhancing image analysis and workflow management for the pathology field. Its technology is particularly beneficial for research and educational applications within the pathology and biopharma markets. By improving the quality of diagnoses and facilitating the review and sharing of extensive clinical data, PathXL's offerings support pathologists in their critical role in diagnosing and treating various diseases, including cancer. Through its innovative tools, the company contributes to better patient outcomes and the advancement of new therapies.

PathXL

Venture Round in 2013
PathXL is a Northern Ireland-based company specializing in digital pathology image analysis, workflow software, and educational tools. The company develops software solutions aimed at enhancing image analysis and workflow management for the pathology field. Its technology is particularly beneficial for research and educational applications within the pathology and biopharma markets. By improving the quality of diagnoses and facilitating the review and sharing of extensive clinical data, PathXL's offerings support pathologists in their critical role in diagnosing and treating various diseases, including cancer. Through its innovative tools, the company contributes to better patient outcomes and the advancement of new therapies.

PathXL

Venture Round in 2013
PathXL is a Northern Ireland-based company specializing in digital pathology image analysis, workflow software, and educational tools. The company develops software solutions aimed at enhancing image analysis and workflow management for the pathology field. Its technology is particularly beneficial for research and educational applications within the pathology and biopharma markets. By improving the quality of diagnoses and facilitating the review and sharing of extensive clinical data, PathXL's offerings support pathologists in their critical role in diagnosing and treating various diseases, including cancer. Through its innovative tools, the company contributes to better patient outcomes and the advancement of new therapies.

PathXL

Venture Round in 2012
PathXL is a Northern Ireland-based company specializing in digital pathology image analysis, workflow software, and educational tools. The company develops software solutions aimed at enhancing image analysis and workflow management for the pathology field. Its technology is particularly beneficial for research and educational applications within the pathology and biopharma markets. By improving the quality of diagnoses and facilitating the review and sharing of extensive clinical data, PathXL's offerings support pathologists in their critical role in diagnosing and treating various diseases, including cancer. Through its innovative tools, the company contributes to better patient outcomes and the advancement of new therapies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.